|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||20.50 - 20.50|
|52-week range||20.25 - 27.76|
|Beta (5Y monthly)||0.26|
|PE ratio (TTM)||15.02|
|Forward dividend & yield||0.51 (2.38%)|
|Ex-dividend date||30 Mar 2023|
|1y target est||N/A|
Ono Pharmaceutical Co. (OPHLF) possesses solid growth attributes, which could help it handily outperform the market.
Ono Pharmaceutical Co. (OPHLF) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is how Acadia Healthcare (ACHC) and Ono Pharmaceutical Co. (OPHLF) have performed compared to their sector so far this year.